Skip to content

Robert Foxman

Patient Partner, Montréal, QC, Canada.

3 papers in the library · 26 citations · publishing 2024-2025

Papers

Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey

Palliative Medicine January 22, 2024 Louis Plourde, Sue-Ling Chang, Houman Farzin et al. 22 citations

A survey of 2,800 adults in four Canadian provinces found high social acceptability of psilocybin-assisted therapy for existential distress at the end of life. 79.3% considered it a reasonable medical choice, 84.8% agreed public health insurance should cover it, and 63.3% would support legalization for medical purposes. More favorable attitudes were linked to prior psilocybin use, exposure to palliative care, and progressive political orientation. The findings suggest public support is strong enough to help mobilize resources and improve access to this emerging therapy in palliative and end-of-life care.

Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care

Palliative Medicine Reports April 17, 2025 Michel Dorval, Sue-Ling Chang, Houman Farzin et al. 3 citations

A forum in Quebec, Canada, with 57 participants including patients, healthcare professionals, researchers, and policymakers, produced 16 recommendations for expanding access to psilocybin-assisted psychotherapy in palliative care. The recommendations address patient eligibility and equity, regulatory frameworks and respect for autonomy, logistical and organizational aspects, professional education and training, public awareness and information, and research. The report suggests these recommendations could guide similar efforts in other jurisdictions facing barriers to this therapy.

Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy

Healthcare September 12, 2025 Ariane Bélanger, Sue-Ling Chang, Jean-François Stephan et al. 1 citation

A decision aid for psilocybin-assisted therapy (PAT) was developed to help patients and healthcare professionals weigh risks and benefits when considering treatment for existential distress in serious illness. The booklet, created with a multidisciplinary steering committee following international standards, covers PAT education, treatment comparisons, and personal reflection. Feedback from five patients and five healthcare professionals guided refinements to improve clarity, balance, and usability. The final version met acceptability and usability criteria, offering balanced information to support shared decision-making in palliative care.